Research - 7investing 7investing

Want access to stock ideas and free investing content? Join our free 7investing email list today!

Stock Market Research

Better investing begins with better research.

7investing Stock Market Research

Being your own investor doesn’t mean you have to go it alone. Improve your investing insights with the stock market research of the 7investing lead advisors. 

Our team dives deeper, going beyond the tickers and trends to provide you with the credible, actionable information you need to make the right moves and achieve your stock market investing goals. Read on to stay up to date with the latest 7investing research articles, podcasts, videos, and updates on your favorite companies. 


7investing's Semiconductor Roundtable: Advanced Micro Devices

Feb 7, 2023

How should you invest in semiconductors? 7investing's advisors Simon Erickson and Krzysztof Piekarski and external guests Jose Najarro and Nick Rossolillo share several stock ideas in the chip industry.

Featured Articles


Is Alphabet’s Advertising Business Ex-Growth?

Feb 6, 2023

Google's ad business faced a rare year-over-year decline. Timing couldn't be worse given the hype around language models like OpenAI's ChatGPT and the thought that these new tools could disrupt...


3 Shareholder-Friendly Companies to Navigate Market Volatility

Feb 6, 2023

Looking for a hedge against market volatility? 7investing CEO Simon Erickson explains why Tractor Supply, CME Group, and Ubiquiti Inc could be calmer waters within the storm.


Investing in Cloud Computing with Muji

Jan 30, 2023

Hhhypergrowth founder muji shares several of cloud computing's key investing takeaways with 7investing founder Simon Erickson

Recent Research


That’s a Wrap for JPM 2023! What are the Key…

Jan 20, 2023

7investing advisor Dana Abramovitz shares several of her key takeaways from the JP Morgan 2023 health care conference.


Seres Therapeutics: A Microbiome Leader With a Huge Upcoming Catalyst

Jan 11, 2023

Seres Therapeutics is a biotech stock for your watch list. 7investing CEO Simon Erickson describes why the pending approval of its flagship drug could be significant for investors.


Move Over Tech, It’s Healthcare’s Week in the Spotlight

Jan 8, 2023

Las Vegas may have been buzzing (literally) with all of the latest and greatest technology at CES this past week, but those of us interested in the health care industry know to save our energy for...


Why Do Companies Pay Dividends?

Dec 9, 2022

Dividends are among the most-beloved aspects of long-term investing. But why do companies pay them in the first place?


Is Online Dating Good Business?

Dec 6, 2022

With romance in the air (and on the TV) during the holidays, we take a look at the business of online-dating.


Enterprise Software: Time To Be Fearful Or Greedy?

Dec 2, 2022

Enterprise software stocks have experienced quite the battering. And it appears there is no end to this shellacking with many earnings reports driving the stocks further down. Is enterprise software...


What Alexa Can Tell Us About The Metaverse

Nov 18, 2022

With the massive layoffs at Amazon, are there some lessons here regarding the latest craze in the metaverse? Anirban weighs in.


dLocal: A Young Payments Business For The Watchlist

Nov 16, 2022

Anirban dove into dLocal's recent Q3 2022 report and explains why the company deserves a spot on your watchlist.


How Should Intel Navigate the Coming Storms?

Nov 6, 2022

Intel is simultaneously looking to expand its production capacity, find design wins in the data center, and maintain good standing with institutions. What path should take priority, and what will...


Why Apple’s Stock Is Beating Microsoft, Alphabet, and Amazon

Nov 4, 2022

Apple generated over $110 billion in free cash flow during its fiscal 2022, up 20% year-over-year. Anirban reviews the company's recently reported Q4 2022 earnings and discusses the road ahead...


Our Top Stock Picks for November 2022

Nov 1, 2022

7investing's November recommendations are now live! Come take a look at the 7 stocks our advisors have chosen as their favorite opportunities in the market this month.


How to Invest in Biotechnology

Oct 27, 2022

7investing's resident biotech PhD shares some valuable lessons about what to look for when investing in this space.


The ABCs of ADRs (and GDRs!)

Oct 26, 2022

Luke Hallard explores the mechanics of when and how to buy a Depositary Receipt.


The “Buy Versus Build” Decision

Oct 23, 2022

The digital world moves quickly. How should companies approach innovation?


Are The iPhone Scuttlebutts Giving You A Migraine?

Oct 19, 2022

Ever since Apple's fall event announced the arrival of the new iPhone 14 and iPhone 14 Pro models, there's constant speculation about the demand or lack thereof for these smartphones. How should we...


Explaining the Stock Market’s Wild Post-CPI Swings

Oct 14, 2022

The market plunged -- and rallied -- after another hotter-than-expected CPI reading this week. Here's what investors need to know.

Premium Special Report

7investing’s Strong Buy Portfolio Update: October 2022

Oct 7, 2022


Welcome to 7investing in October!

Oct 3, 2022

7investing's October recommendations are now live! Come take a look at the 7 stocks our advisors have chosen as their favorite opportunities in the market this month.


DEI in Health Care: More Important than You Think

Sep 30, 2022

Lead Advisor Dana Abramovitz discusses the importance of diversity in clinical trials.


Is It Finally Time for Growth Stocks to Shine Again?

Sep 26, 2022

It might seem crazy given current market volatility, but now might be the perfect time for growth stocks to shine once again.


The Incrementally Innovative Apple

Sep 21, 2022

Incremental innovation is a necessity for success and there's no better proof than Apple's recent "far out" event. Read on for Anirban's take on Apple's recently release iPhones and what this might...


5 Things Investors Should Know About Student Loan Forgiveness

Sep 18, 2022

Finally, we've received clarity on student loan forgiveness and repayment. Here's what investors need to know.


Is Fastly Primed For a Rebound?

Sep 14, 2022

We look into Fastly's Q2 2022 report and try to decipher whether or not now is the time to invest for a rebound.


Is Macro Finally Catching Up With Enterprise Software?

Sep 10, 2022

Anirban checks in on enterprise software behemoths Microsoft & Salesforce to see how they are managing macroeconomic headwinds...


Why Small Modular Nuclear Reactors Could Be The Future of…

Sep 9, 2022